U.S. Chemiluminescence Immunoassay Market Size & Outlook

The chemiluminescence immunoassay market in the United States is expected to reach a projected revenue of US$ 4,621.6 million by 2028. A compound annual growth rate of 7.1% is expected of the United States chemiluminescence immunoassay market from 2021 to 2028.
Revenue, 2020 (US$M)
$2,671.9
Forecast, 2028 (US$M)
$4,621.6
CAGR, 2021 - 2028
7.1%
Report Coverage
U.S.

U.S. chemiluminescence immunoassay market, 2016-2028 (US$M)

U.S.

U.S. chemiluminescence immunoassay market highlights

  • The U.S. chemiluminescence immunoassay market generated a revenue of USD 2,671.9 million in 2020 and is expected to reach USD 4,621.6 million by 2028.
  • The U.S. market is expected to grow at a CAGR of 7.1% from 2021 to 2028.
  • In terms of segment, consumables was the largest revenue generating product & services in 2020.
  • Consumables is the most lucrative product & services segment registering the fastest growth during the forecast period.


Chemiluminescence immunoassay market data book summary

Market revenue in 2020USD 2,671.9 million
Market revenue in 2028USD 4,621.6 million
Growth rate7.1% (CAGR from 2020 to 2028)
Largest segmentConsumables
Fastest growing segmentConsumables
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationConsumables, Instruments, Software & Services
Key market players worldwideDiasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura


Other key industry trends

  • In terms of revenue, U.S. accounted for 36.4% of the global chemiluminescence immunoassay market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In North America, U.S. chemiluminescence immunoassay market is projected to lead the regional market in terms of revenue in 2028.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 589.2 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Chemiluminescence Immunoassay Market Scope

Chemiluminescence immunoassay market segmentation & scope
Consumables
Automated
Semi Automated
Software & Services
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease testing
Autoimmune Disease
Others
Hospitals
Clinical laboratories
Pharmaceutical & biotechnology companies
Others ( Research Institutes, Clinics, CRO)

Chemiluminescence Immunoassay Market Companies

Name Profile # Employees HQ Website

U.S. chemiluminescence immunoassay market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 65.57% in 2020. Horizon Databook has segmented the U.S. chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.


The growth in this region can mainly be attributed to high adoption of technologically advanced CLIA products, favorable reimbursement scenario, and increase in the prevalence of chronic & infectious diseases.

According to CDC estimates, in 2018, around 37,377 new cases of HIV were diagnosed in the U.S. The data from the same source states that 115,045 new cases of syphilis were recorded in 2018. Moreover, according to American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S.

In addition, local presence of leading players in the U.S. and continuous strategic initiatives undertaken by them are anticipated to fuel the market growth. For instance, in October 2020, DiaSorin, an Italy-based CLIA manufacturer, received FDA’s EUA for its new LIAISON SARS-CoV-2 IgM test.

Reasons to subscribe to U.S. chemiluminescence immunoassay market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. chemiluminescence immunoassay market databook

  • Our clientele includes a mix of chemiluminescence immunoassay market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into U.S. chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. chemiluminescence immunoassay market size, by product & services, 2016-2028 (US$M)

U.S. Chemiluminescence Immunoassay Market Outlook Share, 2020 & 2028 (US$M)

U.S. chemiluminescence immunoassay market size, by product & services, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more